Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 206 entries
View as:

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Phase: N/A Priority: Normal
NCT ID: NCT02849873 Org: User:
Start: 06/30/16 End: 01/31/17 Due: 01/31/18

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03664739 Org: User:
Start: 12/05/18 End: 03/23/20 Due: 03/23/21

DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles

Phase: N/A Priority: Normal
NCT ID: NCT00444210 Org: User:
Start: 06/30/04 End: 04/30/06 Due: 04/30/07

Canadian Aesthetic Experience With Sculptra Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00447551 Org: User:
Start: 01/31/07 End: 04/30/08 Due: 04/30/09

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Phase: N/A Priority: Normal
NCT ID: NCT00714714 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03240809 Org: User:
Start: 01/24/20 End: 07/31/24 Due: 07/31/25

Biopsy Study for Sculptra (Poly-L-Lactic Acid)

Phase: N/A Priority: Normal
NCT ID: NCT00869687 Org: User:
Start: 03/31/09 End: 05/31/10 Due: 05/31/11

Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis

Phase: N/A Priority: Normal
NCT ID: NCT02767947 Org: User:
Start: 02/08/16 End: 09/22/16 Due: 09/22/17

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00402038 Org: User:
Start: 02/29/04 End: 10/31/05 Due: 10/31/06

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00269438 Org: User:
Start: 12/31/05 End: 06/30/07 Due: 06/30/08

Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain

Phase: N/A Priority: Normal
NCT ID: NCT00605644 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT02493452 Org: User:
Start: 06/30/15 End: 02/28/17 Due: 02/28/18

Compassionate Use Study of Methylnaltrexone

Phase: N/A Priority: Normal
NCT ID: NCT01368562 Org: User:
Start: 01/24/03 End: 06/02/08 Due: 06/02/09

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

Phase: N/A Priority: Normal
NCT ID: NCT02812771 Org: User:
Start: 08/04/16 End: 01/14/19 Due: 01/14/20

Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT00612105 Org: User:
Start: 10/31/07 End: 12/31/09 Due: 12/31/10

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03170388 Org: User:
Start: 10/05/17 End: 04/23/19 Due: 04/23/20

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04551768 Org: User:
Start: 02/10/21 End: 08/17/21 Due: 08/17/22

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01708603 Org: User:
Start: 08/31/12 End: 10/31/15 Due: 10/31/16

Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01705938 Org: User:
Start: 10/31/12 End: 12/31/12 Due: 12/31/13

A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®

Phase: N/A Priority: Normal
NCT ID: NCT03551873 Org: User:
Start: 06/21/18 End: 12/14/18 Due: 12/14/19

A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip

Phase: N/A Priority: Normal
NCT ID: NCT00325858 Org: User:
Start: 01/31/02 End: 12/31/03 Due: 12/31/04

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT01722318 Org: User:
Start: 11/30/12 End: 10/31/14 Due: 10/31/15

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04857112 Org: User:
Start: 09/29/21 End: 09/30/24 Due: 09/30/25

A Study of Acne Treatment in Children Ages 9 to 11

Phase: N/A Priority: Normal
NCT ID: NCT00907335 Org: User:
Start: 02/28/09 End: 12/31/09 Due: 12/31/10

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Phase: N/A Priority: Normal
NCT ID: NCT01367587 Org: User:
Start: 04/30/02 End: 07/31/02 Due: 07/31/03